Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency

@inproceedings{Ferreira2013EfficacyAS,
  title={Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency},
  author={Juan Camilo Arjona Ferreira and Michel Marre and Nir Barzilai and Hua Guo and Gregory T. Golm and Christine McCrary Sisk and Keith D. Kaufman and Barry J. Goldstein},
  booktitle={Diabetes care},
  year={2013}
}
OBJECTIVE Patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease have an increased risk of micro- and macrovascular disease, but limited options for antihyperglycemic therapy. We compared the efficacy and safety of sitagliptin with glipizide in patients with T2DM and moderate-to-severe chronic renal insufficiency and inadequate glycemic… CONTINUE READING